Scientific and Regulatory Considerations for Assessment of Immunogenicity Risk for Generic Peptide and Oligonucleotide Drug Products October 7 - 8, 2024

https://www.fda.gov/drugs/news-events-human-drugs/scientific-and-regulatory-considerations-assessment-immunogenicity-risk-generic-peptide-and?utm_medium=email&utm_source=govdelivery